COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,308 Articles (22,772 medRxiv, 8,536 bioRxiv)

Most recent first Previous |  Page 1861: Articles 18601-18610  | Next

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Personalized Virology Initiative (PVI) Study Group, , Krammer, F., Simon, V., Martinez-Sobrido, L., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.26.21250543 — Posted: 2021-01-29
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study
Theuring, S., Thielecke, M., van Loon, W., Hommes, F., Huelso, C., von der Haar, A., Koerner, J., Schmidt, M., Boehringer, F., Mall, M. A., Rosen, A., von Kalle, C., Kirchberger, V., Kurth, T., Seybold, J., Mockenhaupt, F. P., BECOSS Study Group
10.1101/2021.01.27.21250517 — Posted: 2021-01-29 Discussion: Offsite
Evaluation of spike protein antigens for SARS-CoV-2 serology
Jagtap, S., K, R., Valloly, P., Sharma, R., Maurya, S., Gaigore, A., Ardhya, C., Biligi, D. S., Desiraju, B. K., Natchu, U. C. M., Saini, D. K., Roy, R.
10.1101/2021.01.27.21250382 — Posted: 2021-01-29
THE AIRBORNE CONTAGIOUSNESS OF RESPIRATORY VIRUSES: A COMPARATIVE ANALYSIS AND IMPLICATIONS FOR MITIGATION
Mikszewski, A., Stabile, L., Buonanno, G., Morawska, L.
10.1101/2021.01.26.21250580 — Posted: 2021-01-29
Lumipulse G SARS-CoV-2 Ag Assay Evaluation for SARS-CoV-2 Antigen Detection Using 594 Nasopharyngeal Swab Samples from Different Testing Groups
Menchinelli, G., Bordi, L., Marzialiotti, F., Palucci, I., Capobianchi, M. R., Sberna, G., Lalle, E., Romano, L., De Angelis, G., Marchetti, S., Sanguinetti, M., Cattani, P., Posteraro, B.
10.1101/2021.01.26.21250533 — Posted: 2021-01-29
Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical Clustering
Di Castelnuovo, A., Gialluisi, A., The COVID-19 RISK and Treatments (CORIST) Collaboration, , Iacoviello, L.
10.1101/2021.01.27.21250238 — Posted: 2021-01-29
Post-Mendelian genetic model in COVID-19
Picchiotti, N., Benetti, E., Fallerini, C., Daga, S., Baldassarri, M., Fava, F., Zguro, K., Valentino, F., Doddato, G., Giliberti, A., Tita, R., Amitrano, S., Bruttini, M., Di Sarno, L., Iuso, N., Alaverdian, D., Beligni, G., Croci, S., Meloni, I., Pinto, A. M., Gabbi, C., Ceri, S., Esposito, A., Pinoli, P., Crawley, F. P., Frullanti, E., Mari, F., GEN-COVID Multicenter Study, , Gori, M., Renieri, A., Furini, S.
10.1101/2021.01.27.21250593 — Posted: 2021-01-29
Spike mutations decrease SARS-CoV-2 sensitivity to neutralizing antibodies but not ACE2-Ig in vitro
Yao, W., Wang, Y., Ma, D., Tang, X., Wang, H., Li, C., Lin, H., Li, Y., Zhong, G.
10.1101/2021.01.27.428353 — Posted: 2021-01-28
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
Dong, J., Zost, S., Greaney, A., Starr, T. N., Dingens, A. S., Chen, E. C., Chen, R., Case, B., Sutton, R., Gilchuk, P., Rodriguez, J., Armstrong, E., Gainza, C., Nargi, R., Binshtein, E., Xie, X., Zhang, X., Shi, P.-Y., Logue, J., Weston, S., McGrath, M., Frieman, M., Brady, T., Tuffy, K., Bright, H., Loo, Y.-M., McvTamney, P., Esser, M., Carnahan, R., Diamond, M., Bloom, J., Crowe, J. E.
10.1101/2021.01.27.428529 — Posted: 2021-01-28
Coronavirus associated molecular mimicry common to SARS-CoV-2 peptide
Adiguzel, Y.
10.1101/2021.01.28.428642 — Posted: 2021-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).